Abalone Bio

Abalone Bio

Abalone Bio designs antibody therapeutics by prioritizing biological function over structural binding to activate hard-to-drug disease targets.

Contact for pricingWeb
Visit websiteabalonebio.com
Compare with DataRobotExplore Abalone Bio alternatives

Overview

Abalone Bio designs antibody therapeutics by prioritizing biological function over structural binding to activate hard-to-drug disease targets. Utilizing its proprietary FAST platform, it biologically measures pharmacological activity for 100 million antibodies in a single experiment, offering throughput 100 times higher than existing technologies. The large-scale activity datasets collected power machine learning algorithms to discover optimized drug candidates for difficult targets. The company focuses on challenging protein classes like GPCRs, supporting the development of obesity and metabolic disease treatments with minimal side effects. Target users include pharmaceutical companies and biotech firms seeking solutions to drug discovery challenges, accessible through business partnerships.

Key features

  • Biological measurement of 100 million antibodies for pharmacological activity
  • Machine learning powered by proprietary large-scale activity datasets
  • Discovery of antibody agonists for G-protein coupled receptors (GPCRs)

Pros & cons

Collected from user feedback found in web search

Pros

  • High ratings for culture and values (5.0)
  • Excellent diversity and inclusion (5.0)
  • Good science and management
  • Nice working environment

Pricing

Contact for pricingStarting price: Contact for pricing
View pricing page

Verified on:

Use cases

  • Developing treatments for obesity and metabolic diseases
  • Discovering activators for hard-to-drug GPCR targets
  • High-throughput screening to identify functional antibodies

Who it is for

Biotechpharmaceutical companies

Integrations

CoiledPipeBioAWSGoogle Cloud

Tags

API

How we verified this

Company, pricing, and feature details come from the primary sources below and our latest verification pass. When sources disagree, the official source and the most recent check win.

Last verified 09/06/2026Verified sources: 2

Alternatives

Tools you can use instead